These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3619946)

  • 1. 3H-spiroperidol binding sites in blood platelets.
    Khanna AS; Agrawal AK; Seth PK
    Biochem Biophys Res Commun; 1987 Aug; 146(3):983-8. PubMed ID: 3619946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE; Ciaranello RD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytes of healthy subjects and schizophrenic patients possess no high-affinity binding sites for spiroperidol.
    Rao ML; Deister A; Roth A
    Pharmacopsychiatry; 1990 Jul; 23(4):176-81. PubMed ID: 2381986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of serotonin receptors in rat uterus induced by estradiol.
    Ichida S; Tokunaga H; Oda Y; Fujita N; Hirata A; Hata T
    J Biol Chem; 1983 Nov; 258(22):13438-43. PubMed ID: 6643435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T; Iwata K
    Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]Spiroperidol binding in rat striatum: two high-affinity sites of differing selectivities.
    Andorn AC; Maguire ME
    J Neurochem; 1980 Nov; 35(5):1105-13. PubMed ID: 6256500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo modulation of brain dopamine recognition sites: a possible model for emission computed tomography studies.
    Ferrero P; Vaccarino F; Guidotti A; Costa E; Di Chiro G
    Neuropharmacology; 1983 Jun; 22(6):791-5. PubMed ID: 6604240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]-Spiroperidol labels dopamine receptors in membranes from rabbit mesenteric artery.
    Brodde OE; Gross G
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Apr; 311(3):249-54. PubMed ID: 7393340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum.
    Huff RM; Molinoff PB
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7561-5. PubMed ID: 6961433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.
    Armstrong RA; Humphrey PP; Lumley P
    Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterisation of dopamine receptors in the superior colliculus of the rat.
    Weller ME; Rose S; Jenner P; Marsden CD
    Neuropharmacology; 1987 Apr; 26(4):347-54. PubMed ID: 2438586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-2 dopamine receptors in the frontal cortex of rat and human.
    Liskowsky DR; Potter LT
    Life Sci; 1985 Apr; 36(16):1551-9. PubMed ID: 3982225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the interactions of antiestrogens with pituitary and striatal dopamine receptors.
    Toney TW; Katzenellenbogen BS
    J Recept Res; 1987; 7(5):695-712. PubMed ID: 2958626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.